Why the study?
Does ticagrelor added to standard aspirin improve saphenous vein graft patency in patients undergoing coronary artery bypass grafting?
RCT
double-blind
randomized
Yes
Does ticagrelor added to standard aspirin improve saphenous vein graft patency in patients undergoing coronary artery bypass grafting?
Absolute Event Rate: 11% vs 9%
Adding ticagrelor to aspirin does not improve saphenous vein graft patency after CABG, highlighting the persistent challenge of early graft failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Steven Goldman (2020) conducted an RCT in Patients undergoing coronary artery bypass grafting (CABG). Ticagrelor added to aspirin vs. Aspirin alone was evaluated on Saphenous vein graft (SVG) patency.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: